Kyle Fletcher - 15 Mar 2024 Form 4 Insider Report for Celularity Inc (CELU)

Role
Executive Vice President, General Counsel
Signature
/s/ Kyle Fletcher
Issuer symbol
CELU
Transactions as of
15 Mar 2024
Net transactions value
-$3,505
Form type
4
Filing time
19 Mar 2024, 09:20:28 UTC
Previous filing
21 Feb 2024
Next filing
16 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELU Class A Common Stock Tax liability $3,505 -617 -2.8% $5.68* 21,105 15 Mar 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.
F2 Includes 20,372 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.
F3 On February 29, 2024, the Issuer effected a 1-for-10 reverse stock split (the "Reverse Stock Split") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Remarks:

Executive Vice President, General Counsel